GO:0033567 DNA replication, Okazaki fragment processing: Lagging-Strand Maturation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0033567 describes the lagging-strand DNA metabolic process in which RNA primers are removed from Okazaki fragments, the resulting gaps are filled by DNA polymerization, and the ends are ligated into a continuous strand.
• Okazaki fragment processing is coordinated at the replication fork by the dynamic DNA-bound PCNA complex, which organizes synthesis, processing and ligation steps.
• RNA:DNA hybrids derived from Okazaki fragments can act as a signal that establishes a Ku-mediated barrier to replication-fork degradation.
• PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed, linking this process to PARP inhibitor biology.
• Unprocessed replication gaps, including those arising from defective Okazaki fragment maturation, are key determinants of PARP inhibitor synthetic lethality in BRCA-deficient cells.
• Replicative gaps in DNA damage tolerance are increasingly recognized as contributors to genome instability and cancer therapy response.
Description
DNA replication, Okazaki fragment processing (GO:0033567) is the biological process that matures the short, discontinuous DNA pieces synthesized on the lagging strand during genome duplication. Because DNA polymerases synthesize only in the 5-prime to 3-prime direction, the lagging strand is built as a series of Okazaki fragments, each initiated by an RNA primer; these fragments must subsequently be processed into a continuous DNA strand. The QuickGO definition captures this as the DNA metabolic process, occurring during lagging strand synthesis, by which RNA primers are removed from Okazaki fragments, the resulting gaps filled by DNA polymerization, and the ends ligated to form a continuous strand. This process is essential for faithful chromosome duplication and for maintaining replication fork integrity. Researchers study GO:0033567 because defects in Okazaki fragment maturation generate replication gaps and RNA:DNA hybrids that influence fork stability, DNA damage responses and sensitivity to clinical drugs such as PARP inhibitors. The dynamic coordination of synthesis, processing and ligation by DNA-bound PCNA complexes makes this term a focal point for understanding replisome organization and genome maintenance. In addition, recent work has linked Okazaki fragment processing to replication fork speed control and to the broader biology of replicative gaps in DNA damage tolerance and cancer therapy.
DNA replication, Okazaki fragment processing At A Glance
| GO ID | GO:0033567 |
|---|---|
| GO term | DNA replication, Okazaki fragment processing |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Removal of RNA primers from Okazaki fragments, gap filling by DNA polymerization, and ligation into a continuous lagging strand |
| Process context | Occurs during lagging strand synthesis at the eukaryotic DNA replication fork |
| Key coordinator | Dynamic DNA-bound PCNA complexes coordinate Okazaki fragment synthesis, processing and ligation |
| Related signaling | PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed |
| Disease relevance | Replication gaps from defective processing contribute to PARP inhibitor synthetic lethality with BRCA deficiency |
What Is GO:0033567?
In simple terms, GO:0033567 is the clean-up and joining step that turns the many small pieces of newly made lagging-strand DNA into one continuous strand. Formally, it is the DNA metabolic process, occurring during lagging strand synthesis, by which RNA primers are removed from Okazaki fragments, the resulting gaps filled by DNA polymerization, and the ends ligated to form a continuous strand. This process depends on the coordinated action of replication proteins at the fork, including the sliding clamp PCNA, and it is coupled to lagging-strand synthesis and ligation.
Why Is DNA replication, Okazaki fragment processing Important in Cell Biology?
Okazaki fragment processing is important because it determines whether the lagging strand is converted into an intact, continuous DNA molecule during every round of genome duplication. Failure or inefficiency in this process leaves replication gaps and RNA:DNA hybrids that can alter fork stability and DNA damage signaling. Because PARP1 activity and BRCA status influence how cells respond to unprocessed Okazaki fragments, this process is directly relevant to cancer therapy and synthetic lethality. Understanding GO:0033567 therefore connects fundamental replisome mechanics to clinically actionable vulnerabilities in cancer cells.
• Ensures continuous lagging-strand DNA synthesis by removing RNA primers and ligating Okazaki fragments.
• Coordinates synthesis, processing and ligation through dynamic DNA-bound PCNA complexes.
• Generates RNA:DNA hybrids that can establish a Ku-mediated barrier to replication-fork degradation.
• Is promoted by PARP1 auto-modification, which also limits replication fork speed.
• Contributes to replication gaps that determine PARP inhibitor synthetic lethality in BRCA-deficient cells.
• Links to DNA damage tolerance and genome instability relevant to cancer therapy.
• Provides a mechanistic basis for studying replisome-mediated DNA replication.
• Helps explain how lagging-strand maturation defects may influence disease-associated genome maintenance pathways.
What Happens During DNA replication, Okazaki fragment processing?
Initiation and synthesis of Okazaki fragments
In simple terms: The lagging strand is made in short pieces, each starting with a small RNA primer.
During lagging strand synthesis, DNA polymerases synthesize short Okazaki fragments that are initiated by RNA primers. Replisome-mediated DNA replication coordinates leading- and lagging-strand synthesis so that these fragments are produced repeatedly as the fork progresses. The dynamic DNA-bound PCNA complexes help organize the synthesis step and prepare fragments for subsequent processing.
RNA primer removal and gap filling
In simple terms: The RNA starter is removed and the leftover gap is filled with DNA.
GO:0033567 explicitly includes removal of RNA primers from Okazaki fragments and filling of the resulting gaps by DNA polymerization. This maturation step converts primer-containing intermediates into DNA-only segments that can be joined. PCNA complexes coordinate this processing with synthesis and ligation at the fork.
Ligation into a continuous strand
In simple terms: The finished DNA pieces are sealed together into one long strand.
After gap filling, the ends of adjacent Okazaki fragments are ligated to form a continuous strand, completing the processing reaction defined by GO:0033567. The coordination of synthesis, processing and ligation by DNA-bound PCNA complexes is central to efficient completion of this step. Replisome-mediated replication provides the broader context in which this ligation occurs.
RNA:DNA hybrids and fork protection
In simple terms: Leftover RNA-DNA hybrids from Okazaki fragments can act as a signal that protects the fork.
RNA:DNA hybrids from Okazaki fragments contribute to establishing the Ku-mediated barrier to replication-fork degradation. This links the processing of Okazaki fragments to fork stability and to pathways that monitor replication stress. Such hybrids are therefore not merely intermediates but can influence fork protection and degradation decisions.
PARP1, fork speed and faithful processing
In simple terms: PARP1 helps Okazaki fragments be processed correctly and keeps fork speed in check.
PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed. This places GO:0033567 within a regulatory network that couples lagging-strand maturation to replication timing and fork progression. Defects in this coordination can leave replication gaps that affect cell survival and drug response.
Key Genes Involved in GO:0033567 DNA replication, Okazaki fragment processing
The genes and proteins most directly associated with GO:0033567 include replication fork components, PCNA-associated factors, PARP1 and DNA damage response proteins that influence Okazaki fragment maturation and replication gap biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PCNA | Sliding clamp that coordinates Okazaki fragment synthesis, processing and ligation | Central to studying dynamic DNA-bound complexes at the replication fork |
| PARP1 | Auto-modification promotes faithful Okazaki fragment processing and limits fork speed | Links Okazaki fragment processing to PARP inhibitor biology |
| BRCA1 | BRCA deficiency creates replication gaps that determine PARP inhibitor synthetic lethality | Key model for synthetic lethality studies involving replication gaps |
| BRCA2 | BRCA deficiency creates replication gaps that determine PARP inhibitor synthetic lethality | Key model for synthetic lethality studies involving replication gaps |
| FEN1 | Flap endonuclease implicated in Okazaki fragment maturation | Relevant to RNA primer removal and gap filling steps |
| LIG1 | DNA ligase that seals Okazaki fragments into a continuous strand | Relevant to the ligation step of GO:0033567 |
| POLA1 | Polymerase involved in initiating Okazaki fragments with RNA primers | Relevant to lagging-strand synthesis initiation |
| POLD1 | Polymerase involved in lagging-strand DNA synthesis and gap filling | Relevant to DNA polymerization during processing |
| RNASEH2 | Ribonuclease implicated in RNA:DNA hybrid processing | Relevant to RNA:DNA hybrid biology from Okazaki fragments |
| KU70/KU80 | Ku-mediated barrier to replication-fork degradation | Relevant to fork protection linked to Okazaki fragment hybrids |
| RPA | Single-stranded DNA binding protein at replication forks | Relevant to fork architecture and lagging-strand processing |
| RFC | Clamp loader that loads PCNA at primer-template junctions | Relevant to PCNA dynamics during Okazaki fragment processing |
| DNA2 | Nuclease implicated in Okazaki fragment processing | Relevant to RNA primer removal and flap processing |
| APEX1 | Base excision repair factor potentially linked to replication gap processing | Relevant to replication gap biology |
| XRCC1 | DNA repair factor potentially linked to replication gap processing | Relevant to replication gap biology |
| ATR | Replication stress response kinase | Relevant to cellular responses to unprocessed Okazaki fragments |
| CHEK1 | Checkpoint kinase downstream of replication stress | Relevant to replication gap and fork stability studies |
How Is DNA replication, Okazaki fragment processing Regulated?
Okazaki fragment processing is regulated in part by PARP1 auto-modification, which promotes faithful processing and limits replication fork speed. The process is also coordinated by dynamic DNA-bound PCNA complexes that organize synthesis, processing and ligation steps. RNA:DNA hybrids from Okazaki fragments contribute to a Ku-mediated barrier to replication-fork degradation, linking processing intermediates to fork protection signaling. In addition, replication gaps arising from processing defects engage DNA damage response pathways that influence PARP inhibitor sensitivity in BRCA-deficient cells.
DNA replication, Okazaki fragment processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BRCA1 | PARP inhibitor synthetic lethality with replication gaps | BRCA1 knockout cell line for PARP inhibitor sensitivity assays |
| BRCA2 | PARP inhibitor synthetic lethality with replication gaps | BRCA2 knockout cell line for PARP inhibitor sensitivity assays |
| PARP1 | Okazaki fragment processing and fork speed regulation | PARP1 knockout or auto-modification mutant cell lines |
| KU70/KU80 | Ku-mediated barrier to replication-fork degradation | Ku70/Ku80 knockout cells for fork degradation assays |
| ATR | Replication stress response | ATR knockout or inhibitor-treated cell models |
Cancer therapy and PARP inhibitor synthetic lethality
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency, linking Okazaki fragment processing defects to cancer therapy. PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed, further connecting this process to PARP inhibitor biology. Replicative gaps in DNA damage tolerance are also implicated in genome instability and cancer therapy response.
Replication fork stability and genome maintenance
RNA:DNA hybrids from Okazaki fragments contribute to establishing the Ku-mediated barrier to replication-fork degradation, tying processing intermediates to fork stability. Defects in lagging-strand maturation can therefore influence genome maintenance and replication stress responses. Replisome-mediated DNA replication provides the mechanistic framework for understanding these outcomes.
X-linked pigmentary reticulate disorder and immune defects
NK cell defects have been described in X-linked pigmentary reticulate disorder, a condition linked to defects in a protein involved in nucleic acid metabolism. While the direct connection to GO:0033567 requires further study, this disorder illustrates how defects in DNA/RNA metabolism can affect immune function.
From DNA replication, Okazaki fragment processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene impair Okazaki fragment processing? | Knockout cell line with lagging-strand maturation assays |
| Does a specific mutation in a processing factor alter fork speed? | Point-mutation knock-in cell line with fork speed measurements |
| Can a tagged processing factor be tracked at replication forks? | Tagged knock-in cell line for imaging and proteomics |
| Does overexpression of a processing factor rescue replication gaps? | Overexpression cell line with replication gap assays |
| Does PARP1 auto-modification status affect Okazaki fragment processing? | PARP1 mutant knock-in cell line with processing assays |
| Do RNA:DNA hybrids from Okazaki fragments affect fork degradation? | Knockout or knockdown cells with hybrid detection and fork degradation assays |
How to Study the DNA replication, Okazaki fragment processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| DNA fiber assay | Replication fork speed and gap formation | Testing whether gene loss alters fork progression |
| Replication intermediate analysis | Lagging-strand products and processing intermediates | Assessing RNA primer removal and ligation |
| PCNA complex analysis | Dynamic DNA-bound PCNA complexes | Studying coordination of synthesis, processing and ligation |
| RNA:DNA hybrid detection | Hybrids from Okazaki fragments | Linking processing intermediates to fork protection |
| Genome instability assays | Replication gaps and DNA damage tolerance | Evaluating cancer therapy response |
| PARP inhibitor sensitivity assay | Synthetic lethality with BRCA deficiency | Testing BRCA-pathway dependencies |
| Fork degradation assay | Ku-mediated barrier to fork degradation | Studying fork protection mechanisms |
| CRISPR knockout screening | Candidate genes required for processing | Identifying novel Okazaki fragment processing factors |
Replication intermediate analysis
Okazaki fragment processing can be studied by analyzing replication intermediates and lagging-strand products, which reflect RNA primer removal, gap filling and ligation steps. PCNA complex dynamics during synthesis, processing and ligation can be resolved using DNA-bound complex analysis. These approaches help define whether a gene is required for GO:0033567.
Fork speed and replication gap assays
DNA fiber assays and related replication gap measurements can quantify fork speed and gap formation in cells with altered Okazaki fragment processing. PARP1 auto-modification status is specifically linked to fork speed control and faithful processing. Replication gaps are key determinants of PARP inhibitor synthetic lethality, making these assays central to translational studies.
RNA:DNA hybrid detection
RNA:DNA hybrids from Okazaki fragments can be detected using hybrid-specific reagents and assays to study their role in fork protection. Such experiments connect processing intermediates to the Ku-mediated barrier to replication-fork degradation. This is important for understanding how lagging-strand maturation influences fork stability.
Genome instability and DNA damage tolerance profiling
Replicative gaps in DNA damage tolerance can be profiled to assess genome instability and cancer therapy response. These methods complement processing assays by linking Okazaki fragment maturation defects to downstream genome maintenance outcomes. They are useful for testing candidate genes identified in CRISPR screens.
How CRISPR Can Be Used to Study GO:0033567 DNA replication, Okazaki fragment processing
Knockout
CRISPR knockout of candidate genes such as PCNA, PARP1, BRCA1 or BRCA2 can be used to test whether they are required for Okazaki fragment processing, fork speed control and replication gap formation. Knockout models are particularly useful for synthetic lethality studies with PARP inhibitors.
Point Mutation
Point-mutation knock-in models can dissect specific residues required for PARP1 auto-modification or PCNA function during Okazaki fragment processing. Such models help distinguish catalytic versus regulatory roles in lagging-strand maturation.
Knock-in
Tagged knock-in of processing factors allows visualization and proteomic analysis of DNA-bound complexes at replication forks. Knock-in of disease-relevant variants can model altered Okazaki fragment processing in human cells.
Overexpression
Overexpression of processing factors can test whether increased activity rescues replication gaps or alters fork speed. This approach is useful for validating gain-of-function hypotheses in cancer models.
How EDITGENE Supports DNA replication, Okazaki fragment processing Research
Researchers studying DNA replication, Okazaki fragment processing-related genes often need to determine whether a candidate gene is causally involved in RNA primer removal, gap filling, ligation or fork protection. EDITGENE provides CRISPR-based cell model services that enable such causal tests in relevant human cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for DNA replication, Okazaki fragment processing research.
Frequently Asked Questions About DNA replication, Okazaki fragment processing
What is GO:0033567?
GO:0033567 is the biological process DNA replication, Okazaki fragment processing, in which RNA primers are removed from Okazaki fragments, gaps are filled by DNA polymerization, and ends are ligated into a continuous strand.
What happens during Okazaki fragment processing?
During lagging strand synthesis, RNA primers are removed, gaps are filled by DNA polymerization, and the fragments are ligated into a continuous strand.
What genes are involved in Okazaki fragment processing?
Key genes include PCNA, PARP1, BRCA1, BRCA2, FEN1, LIG1, POLA1, POLD1, RNASEH2, KU70/KU80, RPA, RFC, DNA2, APEX1, XRCC1, ATR and CHEK1.
How is PCNA involved in Okazaki fragment processing?
Dynamic DNA-bound PCNA complexes coordinate Okazaki fragment synthesis, processing and ligation.
How does PARP1 affect Okazaki fragment processing?
PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed.
What are RNA:DNA hybrids from Okazaki fragments?
RNA:DNA hybrids from Okazaki fragments contribute to establishing the Ku-mediated barrier to replication-fork degradation.
Why are replication gaps important in cancer therapy?
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.
How can I study Okazaki fragment processing in the lab?
Common methods include DNA fiber assays, replication intermediate analysis, PCNA complex analysis, RNA:DNA hybrid detection and genome instability assays.
What CRISPR models are useful for studying Okazaki fragment processing?
Knockout, point-mutation, knock-in, tagged knock-in and overexpression models can be used to test gene function in this process.
What diseases are linked to defective Okazaki fragment processing?
Defects in this process are linked to replication gap biology, PARP inhibitor sensitivity in BRCA-deficient cancers and genome instability.
Conclusion
GO:0033567 DNA replication, Okazaki fragment processing is a central lagging-strand maturation process that removes RNA primers, fills gaps and ligates Okazaki fragments into a continuous strand. Its coordination by PCNA complexes and regulation by PARP1 connect it to fork speed control, RNA:DNA hybrid biology and replication gap formation. These features make Okazaki fragment processing a key area for cancer therapy research, particularly PARP inhibitor synthetic lethality with BRCA deficiency. CRISPR-based cell models provide a direct way to test causal roles of candidate genes in this process.
References
- 1. Burgers PMJ et al.. 2017. Eukaryotic DNA Replication Fork.. Annu Rev Biochem 86:417-438 PMID: 28301743
- 2. Elsborg JD et al.. 2025. PARP1 auto-modification promotes faithful Okazaki fragment processing and limits replication fork speed.. Mol Cell 85(19):3562-3575.e10 PMID: 41043391
- 3. Audoynaud C et al.. 2023. RNA:DNA hybrids from Okazaki fragments contribute to establish the Ku-mediated barrier to replication-fork degradation.. Mol Cell 83(7):1061-1074.e6 PMID: 36868227
- 4. Cong K et al.. 2021. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.. Mol Cell 81(15):3128-3144.e7 PMID: 34216544
- 5. Matsumoto Y et al.. 2020. Dynamic DNA-bound PCNA complexes co-ordinate Okazaki fragment synthesis, processing and ligation.. J Mol Biol 432(24):166698 PMID: 33157085
- 6. Benkovic SJ et al.. 2001. Replisome-mediated DNA replication.. Annu Rev Biochem 70:181-208 PMID: 11395406
- 7. Starokadomskyy P et al.. 2019. NK cell defects in X-linked pigmentary reticulate disorder.. JCI Insight 4(21) PMID: 31672938
- 8. Falbo L et al.. 2026. Replicative gaps in DNA damage tolerance, genome instability, and cancer therapy.. Mol Cell 86(7):1200-1216 PMID: 41864203
